论文部分内容阅读
作者将224例门诊胃镜与活检粘膜微生物和病理检查证实的幽门螺旋菌阳性胃炎,随机分成12组,分别给予:维酶素,三九胃泰、氟哌酸、硫糖铝、卡那霉素、呋喃唑酮、甲硝唑3周和6周,庆大霉素,迪乐冲剂6周,复方猴头冲剂,迪乐冲剂8周口服治疗。结果幽门螺旋菌转阴率分别为5.9%,12.5%,14.3%,33.3%,40.0%,36.8%,42.8%,50.0%,50.0%,69.0%,96.0%;其中迪乐冲剂8周口服治疗组显著优于其它各组(P<0.001和P<0.05),复方猴头冲剂8周治疗组也优于维酶素、三九胃泰,氟哌酸和硫糖铝组(P<0.001,P<0.01和P<0.05):特别是迪乐冲剂8周使幽门螺旋菌转阴率由6周的50.0%猛增至96.0%
The author of 224 cases of endoscopy and biopsy mucosal microbes and pathological examination confirmed Helicobacter pylori positive gastritis, were randomly divided into 12 groups were given: Vitex, Sanjuweitai, norfloxacin, sucralfate, kanamycin , Furazolidone, metronidazole 3 weeks and 6 weeks, gentamicin, Di Le granules 6 weeks, compound Herbal Medicine, Di Le granules 8 weeks oral treatment. Results The negative rates of Helicobacter pylori were 5.9%, 12.5%, 14.3%, 33.3%, 40.0%, 36.8%, 42.8%, 50.0%, 50.0%, 69.0%, 96.0% (P <0.001 and P <0.05, respectively), and the Herba Hepatitis A compound 8 weeks treatment group was also superior to Vitex, Sanjiuweitai, norfloxacin and sucralfate group (P <0.001, P < P <0.01 and P <0.05). Especially, the diuretic granules significantly increased the Helicobacter pylori negative rate from 50.0% at 6 weeks to 96.0%